from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2183c/-

LFCtreatmentdescriptionclass of inhibitor

0.519

Amikacinug/mL Amikacintranslation

1.050

Cap5-10ug/mL Capreomycintranslation

1.226

Rox10-50 ug/mL Roxithromycintranslation

1.189

SM2-5 ug/mL Streptomycintranslation

2.237

Tet5-10 ug/mL Tetracyclinetranslation

-0.578

Rif0.2-5ug/mL Rifampicintranscription

0.339

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.281

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.244

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.540

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.154

Clofazimine10-13 ug/mL Clofaziminerespiration

0.250

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.759

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.184

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.704

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.027

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.013

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.015

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.764

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.367

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.435

KCN5-20 ug/mL Potassium cyaniderespiration

-0.310

NaN30.2-2 mM Sodium aziderespiration

0.148

Nigericin50 uM Nigericinrespiration

-0.676

TRC10-150 ug/mL Triclosanrespiration

-0.683

TRZ10-25 ug/mL Thioridazinerespiration

1.452

Valinomycin0.5-10 uM Valinomycinrespiration

-0.007

ZnSO42 mM ZnSO4respiration

0.844

menadione6-10 ug/mL Menadionerespiration

0.048

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.024

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.058

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.139

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.038

NRP_1Non-replicating persistence stage 1dosRassociated

-0.072

Amp0.2mg/mL AmpicillincellWall

-0.245

Cephalexin20-100 ug/mL CephalexincellWall

0.202

Cerulenin0.32-5 ug/mL CerulenincellWall

0.367

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.045

EMB10-20 ug/mL EthambutolcellWall

0.106

Eta12-40 ug/mL EthionamidecellWall

-0.137

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.126

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.064

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.281

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.091

BZA0.12 mg/mL BenzamidearomaticAmides

-0.293

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.201

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.170

H2O24 mM hydrogen peroxideDNAdamaging

0.149

Levo10 ug/mL LevofloxacinDNAdamaging

0.121

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.709

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.016

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.789

UVUV-irradiationDNAdamaging

-0.391

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.225

Antimycin12.5-50 ug/mL Antimycin A?

0.383

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.230

PA_110-50 ug/mL Antitubercular compound PA-1?

0.364

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.098

PA8240.2-2 ug/mL PA-824?

-1.954

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.462

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.110

Verapamil50 uM Verapamil?

0.088

mercaptoethanol2 mM 2-Mercaptoethanol?

0.119

methoxatin10-20 ug/mL Methoxatin?